Brief: China NT Pharma Group says in discussions regarding acquisition of pharmaceutical assets
05/04/2016 05:03
April 5 (Reuters) - China NT Pharma Group Co Ltd 1011.HK : * Voluntary announcement potential acquisition 1011.HK * Company is in discussions with an independent third party regarding the potential acquisition of pharmaceutical assets * The company has not entered into any definitive agreement in relation to the potential acquisition * As at date of announcement, no material terms concerning potential acquisition have been agreed * Source text for Eikon ID:nHKS68JwfD ((For more news, please click here 1011.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY